TrialJournal of clinical lipidology

Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials.

Belinda Schludi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.